United States:
Disclosures Become A Focal Point For Regulators
09 February 2015
Reed Smith
To print this article, all you need is to be registered or login on Mondaq.com.
In a recent Compliance Week article, Keri Bruce and Kevin Madagan discuss the FTC's and
FDA's increased attention to disclosure practices, reminding
companies to review their existing measures. The article underscores the importance for
companies to reeducate themselves and reevaluate approval processes
to help avoid enforcement.
This article is presented for informational purposes only
and is not intended to constitute legal advice.
POPULAR ARTICLES ON: Media, Telecoms, IT, Entertainment from United States
Hiring A Name, Image, And Likeness Agent
McLane Middleton, Professional Association
I am a student-athlete and I want to hire an agent to negotiate NIL contracts for me. Is there anything I should be aware of when hiring an NIL agent?
Carefully Examine Those TCPA Complaints!
Klein Moynihan Turco LLP
Last month, in Woodard v. Health Insurance Alliance ("HIA"), a judge for the United States District Court for the Eastern District of Illinois issued a useful decision for defendants...